Table: Sapporo Clinical Lab -Q1 group results

Sapporo Clinical Laboratory

05/08/2024 07:30

Aug 5 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             5.00                4.92             19.80    
                 (+1.6 pct)          (+0.5 pct)       (+0.6 pct)  
  Operating        98 mln              75 mln           500 mln   
                 (+30.3 pct)         (-42.5 pct)      (-6.4 pct)  
  Recurring        102 mln             80 mln           493 mln   
                 (+26.5 pct)         (-63.8 pct)      (-4.2 pct)  
  Net              56 mln               5 mln           320 mln   
                (+889.0 pct)         (-92.7 pct)      (-15.8 pct) 
  EPS             17.90 yen           1.72 yen        102.36 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T